Niagen Bioscience Inc Live Stock Price Today, Share Analysis and Chart

Name: Niagen Bioscience Inc.: Is Infosys Ltd. worth buying?
Item: Niagen Bioscience Inc.
Rating: 1.15727775
Author: Trendlyne DVM scores

Weak Stock

about

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven t...

3.06 0.02 (0.66%)

70.91% Fall from 52W High

136.3K

XNAS Volume

XNAS 11 Sep, 2026 3:01 PM (EDT)

Low Financial Strength

11.1 / 100

Mid Valuation

45.0 / 100

Technically Bearish

25.4 / 100

Weak Stock These stocks have weak financials and momentum. Buying interest is low. While the stock is affordable, investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 295%

6 analysts

Niagen Bioscience Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Niagen Bioscience Inc Live Stock Price Today, Share Analysis and Chart

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven t...

70.91% Fall from 52W High

SWOT Analysis

Niagen Bioscience Inc Live Price Chart

Niagen Bioscience Inc Live Price Chart